US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

101.47

+0.61000.60%

Post-market: 101.470.00000.00%19:30 EDT

Volume:100.27K

Turnover:10.13M

Market Cap:4.28B

PE:-98.68

High:101.69

Open:100.73

Low:100.51

Close:100.86

52wk High:107.69

52wk Low:90.24

Shares:42.15M

Float Shares:42.15M

Volume Ratio:0.84

T/O Rate:0.24%

Dividend:1.44

Dividend Rate:1.42%

EPS(TTM):-1.0283

EPS(LYR):-1.0283

ROE:-8.66%

ROA:0.90%

PB:1.10

PE(LYR):-98.68

Loading ...

Overview Company News Filings

Trump: Thanks Howard Kessler for senior healthcare innovation

Trump's Truth Social latest posts

Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR

BCAL Diagnostics Evolves Into National Early Cancer Detection Platform

Odyssey Health Extends Promissory Note Maturities to 2027

L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live

Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL

AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS

Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated

THOMSON REUTERS

Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IXJ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IXJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXJ\",,,,,undefined,":{"symbol":"IXJ","market":"US","secType":"STK","nameCN":"iShares Global Healthcare ETF","latestPrice":101.47,"timestamp":1791230400000,"preClose":100.86,"halted":0,"volume":100269,"hourTrading":{"tag":"盘后","latestPrice":101.47,"preClose":101.47,"latestTime":"19:30 EDT","volume":24,"amount":2441.4,"timestamp":1791243002988,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.006047987309141379,"floatShares":42150000,"shares":42150000,"eps":-1.028295,"marketStatus":"Not Yet Opened","change":0.61,"latestTime":"10-05 16:00:00 EDT","open":100.73,"high":101.69,"low":100.51,"amount":10133844.308406001,"amplitude":0.011699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":-1.028295,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791273600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":100.86,"sharesOutstanding":41150000,"nav":100.818098,"aum":4257028169.61,"dividendRate":0.014214,"bidAskSpread":0.001607,"preHourTrading":{"tag":"盘前","latestPrice":102.28,"preClose":100.86,"latestTime":"09:10 EDT","volume":13,"amount":1328.22001,"timestamp":1791205840913,"change":1.42,"changeRate":0.014079,"amplitude":0.014079},"postHourTrading":{"tag":"盘后","latestPrice":101.47,"preClose":101.47,"latestTime":"19:30 EDT","volume":24,"amount":2441.4,"timestamp":1791243002988,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.843965,"impliedVol":0.0413,"impliedVolPercentile":0.3586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IXJ\",,,,,undefined,":{"symbol":"IXJ","floatShares":42150000,"roa":"0.90%","roe":"-8.66%","lyrEps":-1.028295,"volumeRatio":0.843965,"shares":42150000,"dividePrice":1.4423,"high":101.69,"amplitude":0.011699,"preClose":100.86,"low":100.51,"week52Low":90.24,"pbRate":"1.10","psRate":"57.79","week52High":107.685,"institutionHeld":0,"latestPrice":101.47,"eps":-1.028295,"divideRate":0.014214,"volume":100269,"delay":0,"ttmEps":-1.028295,"open":100.73,"prevYearClose":97.4,"prevWeekClose":100.86,"prevMonthClose":102.12,"prevQuarterClose":102.12,"fiveDayClose":104.11,"twentyDayClose":104.9,"sixtyDayClose":99.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IXJ\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IXJ","amount":0.846056,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IXJ","amount":0.597646,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IXJ","amount":0.762798,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IXJ","amount":0.61725,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IXJ","amount":0.67232,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"全球医疗业ETF-iShares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IXJ\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.724079,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.987716,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.517509,"currency":"USD"},{"executeDate":"2018-12-18","recordDate":"2018-12-19","paymentDate":"2018-12-24","value":0.347433,"currency":"USD"},{"executeDate":"2018-12-28","recordDate":"2018-12-31","paymentDate":"2019-01-04","value":0.33206,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IXJ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IXJ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673035563","title":"Trump: Thanks Howard Kessler for senior healthcare innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673035563","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673035563?lang=en_us&edition=fundamental","pubTime":"2026-10-06 11:04","pubTimestamp":1791255864,"startTime":"0","endTime":"0","summary":"President Donald Trump praised his friend and advisor on aging healthcare, Howard Kessler, in an October 6 post on X, thanking him for his work on behalf of Americans aged 65 and older. Trump...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trumpstruth.org/statuses/42175","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","BK4211","NOBL","BK4588","IXJ","XLV","CGCV","BK4550","BK4581","BK4585","DTEC","IDNA","THMZ","HEAL","GINN","LABU","TCAF","HBMD","VHT","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673080374","title":"Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR","url":"https://stock-news.laohu8.com/highlight/detail?id=2673080374","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673080374?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:05","pubTimestamp":1791245145,"startTime":"0","endTime":"0","summary":"Tech Coast Angels reports profitable Atraverse Medical exit after Johnson & Johnson acquisition, citing 70%+ IRRTech Coast Angels reported a profitable exit from Atraverse Medical following its acquis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL17Q5Wq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","LU2750360641.GBP","TRUH","IE00BSNM7G36.USD","LU2417539215.USD","LU1291159041.SGD","LU1066051225.USD","LU0985320562.USD","LU0787776722.HKD","LU0124676726.USD","LU2403377893.USD","LU0912757837.SGD","LU2505996681.GBP","LU1894683348.USD","LU2430703178.SGD","XLV","GDOC","LU2430703095.HKD","JDOC","BK4532","BK4585","IE00BFXG1179.USD","LU1732800096.USD","LU1914381329.SGD","MEDX","VHT","LU1228905037.USD","PJP","FTXH","BMED","SG9999002232.USD","IXJ","RXL","IHE","IE000M9KFDE8.USD","LU0820562030.AUD","LU1221951129.SGD","LU2471134796.USD","LU0345770308.USD","JNJ","LU1935042991.SGD","LU1059921491.USD","LU0122379950.USD","LU0345769128.USD","LU0882574055.USD","LU1244550494.USD","LU2236285917.USD","FHLC","IYH","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673080329","title":"BCAL Diagnostics Evolves Into National Early Cancer Detection Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2673080329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673080329?lang=en_us&edition=fundamental","pubTime":"2026-10-06 07:27","pubTimestamp":1791242850,"startTime":"0","endTime":"0","summary":"BCAL Diagnostics Limited ( ($AU:BDX) ) has issued an announcement. BCAL Diagnostics Limited is an Australian healthcare company focused on developi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bcal-diagnostics-evolves-into-national-early-cancer-detection-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bcal-diagnostics-evolves-into-national-early-cancer-detection-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGCV","BK4588","BK4585","NOBL","IXJ","VHT","TCAF","BK4550","NHLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673824090","title":"Odyssey Health Extends Promissory Note Maturities to 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2673824090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673824090?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:55","pubTimestamp":1791237343,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Odyssey Group International ( ($ODYY) ). Odyssey Health, Inc. operates in the healthcare sector, focusing on de...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/odyssey-health-extends-promissory-note-maturities-to-2027?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/odyssey-health-extends-promissory-note-maturities-to-2027?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NOBL","CGVV","CGCV","BK4588","BK4585","STXV","VHT","IXJ","BK4550","CGDV","TCAF","VTV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673829530","title":"L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2673829530","media":"Reuters","labels":["event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673829530?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:36","pubTimestamp":1791236175,"startTime":"0","endTime":"0","summary":"UPDATE 2-L'Oreal explores unloading chemical-related liabilities, WSJ reportsOct 5 (Reuters)-L'OrealOREP.PAhas engaged restructuring advisers to explore options for rising US legal liabilities linked ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL6N45R14J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","LU1551013342.USD","GDOC","LU2112291526.USD","LU0072461881.USD","LU2430703178.SGD","TRUH","LU0545562505.USD","LU0689626769.HKD","LU1074936037.SGD","RXL","VHT","FTXH","BMED","IE00BFXG1179.USD","IYH","BK4504","HON","IHE","JNJ","LU0640476718.USD","LU0964807845.USD","IXJ","LU0912757837.SGD","MEDX","LU0889566641.SGD","LU2023250330.USD","LU0949170772.SGD","LU0820561818.USD","LU0289961442.SGD","SGXZ57979304.SGD","PJP","LU2403377893.USD","LU0545039389.USD","LU0787776722.HKD","IE00B3PB1722.GBP","LU1228905037.USD","IE00BKVL7J92.USD","HONG","LU2505996509.AUD","LU0289739343.SGD","SG9999002224.SGD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","FHLC","XLV","LU1023059063.AUD","LU2430703251.USD","LU1032466523.USD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084910","title":"Medtronic PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084910?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:38","pubTimestamp":1791232680,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  advanced 1.84% to $87.97 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.Medtronic PLC closed 17.27% short of its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Danaher Corp.  rose 3.34% to $221.21, and Abbott Laboratories  rose 2.67% to $100.10.Trading volume  eclipsed its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","LU1674673691.USD","PJP","SGXZ57979304.SGD","VHT","LU1983299246.USD","SG9999001176.USD","BMED","JNJ","LU1778281490.HKD","SG9999013999.USD","ABT","IHI","IE0004445239.USD","LU1003077747.HKD","LU0211326839.USD","IYH","LU1066051225.USD","LU1145028129.USD","IE00BKVL7J92.USD","LU0070302665.USD","LU2125909593.SGD","MDT","FHLC","MEDX","LU0314106906.USD","LU1061106388.HKD","IE00B3PB1722.GBP","DHR","LU1718418525.SGD","LU0006306889.USD","LU0058720904.USD","LU1989763427.SGD","LU0345770308.USD","IXJ","LU1280957306.USD","LU0122379950.USD","FTXH","LU2063271972.USD","XLV","LU1923622614.USD","FMED","TRUH","SG9999001176.SGD","JDOC","TMED","GDOC","LU2430703095.HKD","LU0943347566.SGD","RXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443382.USD","LU2237443978.SGD","LU1934455194.USD","LU1496350502.SGD","FHLC","LU1003077747.HKD","IE00BLSP4239.USD","IE00B2B36J28.USD","LU0114720955.EUR","LU2129689514.USD","ABBV","LU1267930573.SGD","LU0820561909.HKD","LU2347655073.USD","RXL","AGNG","LU0861579265.USD","LU1670628061.USD","IE000WAW04H5.SGD","SG9999001440.SGD","LU1244550577.SGD","FTXH","GLAM","LU0058720904.USD","LU0708994859.HKD","LU2468319806.SGD","BK4581","IE00BFTCPJ56.SGD","LU0320765646.SGD","LU0965509283.SGD","LU2129689431.USD","LU1934455863.HKD","LU1057294990.SGD","LU1037948897.HKD","LU0823416689.USD","LU1061106388.HKD","PJP","BK4559","BK4550","SG9999003800.SGD","SG9999015945.SGD","LU0122379950.USD","LU1732800096.USD","LU0795875086.SGD","XLV","LU0965509101.SGD","LU1291159041.SGD","LU0289961442.SGD","LU0310800379.SGD","LU1983299246.USD","IE0004445239.USD","LU2357305700.SGD","IE000MB6IJN5.SGD","LU0198837287.USD","BK4566","LU0726765562.USD","IE00B19Z3581.USD","LU1244550221.USD","IE00BGHQF631.EUR","LU1720051108.HKD","LU2089984988.USD","LU2125909593.SGD","LU1430594728.SGD","LU0553294199.USD","LU0395794307.EUR","IE00BVYPNW00.USD","LU1989772923.USD","SG9999011175.SGD","IE0002270589.USD","LU0511384066.AUD","LU1093756325.SGD","LU1093756168.USD","BK4533","IE00B4R5TH58.HKD","LU0057025933.USD","LU2112291526.USD","LU0868494617.USD","TRUH","LU0203347892.USD","LU1720051017.SGD","LU0124676726.USD","IE000SO60NU8.SGD","IXJ","LU1718418525.SGD","SG9999015952.SGD","LU1236620834.HKD","LU0882574055.USD","IE0009355771.USD","LU0234572021.USD","LU2125909247.SGD","LU2237443622.USD","LU0985320562.USD","IE000BZT7R73.USD","IE00BSNM7G36.USD","LU2089283258.USD","LU0256863902.USD","IE00BVYPNV92.GBP","LU1732799900.SGD","LU0289739343.SGD","LU1923622614.USD","VHT","IE0000B7K699.USD","LU1551013425.SGD","JDOC","LU0965509010.AUD","LU2237443549.SGD","LU0432979614.USD","LU0661504455.SGD","LU0456855351.SGD","LU2237443465.HKD","MEDX","IE00B3PB1722.GBP","LU1267930490.SGD","BK4585","IE00BDGV0183.EUR","LU0689626769.HKD","IE000F7OJYX1.SGD","LU0069063385.USD","BK4534","LU0128525929.USD","LU2347655156.SGD","LU0234570918.USD","LU0203345920.USD","IE00B42XCP33.USD","IYH","LU0158827948.USD","LU0912757837.SGD","LU1839511570.USD","IE0002141913.USD","LU0289739699.SGD","LU1670627923.USD","LU1585245621.USD","LU1244550494.USD","LU1934455277.USD","LU0211328371.USD","LU2089284900.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","LU1989772840.SGD","PPH","LU2237443895.HKD","LU0310799852.SGD","LU0738911758.USD","LU0868494708.USD","LU1929549753.HKD","LU0965508806.USD","LU0859254822.USD","LU2023251221.USD","LU1551013342.USD","LU0943347566.SGD","LU0795875169.SGD","LU2357627491.SGD","IE00BJJMRZ35.SGD","LU0098860793.USD","IE00BJT1NW94.SGD","LU1548497426.USD","LU0949170772.SGD","LU2433249047.HKD","LU0029864427.USD","LU0211327993.USD","LU1496350171.SGD","LU1989771016.USD","LU0689472784.USD","LU2087621335.USD","LU0256863811.USD","LU0942090050.USD","LU1162221912.USD","LU1023059063.AUD","LU0472753341.HKD","LU1074936037.SGD","LU1236620750.USD","LU0417517546.SGD","BK4139","LU0820561818.USD","IE00BLSP4452.SGD","SG9999015978.USD","SG9999015986.USD","LU2133065610.SGD","LU2129689605.HKD","LU0170899867.USD","IE00BN8TJ469.HKD","LU1037948541.HKD","LU0545039389.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU2237443978.SGD","LU0943347566.SGD","LU1430594728.SGD","FHLC","LU0553294199.USD","MEDX","IE00B3PB1722.GBP","ABBV","IE00BDGV0183.EUR","LU1267930573.SGD","RXL","LU0128525929.USD","AGNG","BK4534","LU0234570918.USD","LU0203345920.USD","FTXH","GLAM","IYH","LU1162221912.USD","LU0158827948.USD","LU1023059063.AUD","TRUH","IE0002141913.USD","IXJ","IE000SO60NU8.SGD","LU0320765646.SGD","LU1934455863.HKD","LU1236620834.HKD","LU1585245621.USD","LU1236620750.USD","PJP","BK4550","IE000BZT7R73.USD","LU0122379950.USD","SG9999015978.USD","XLV","PPH","LU0170899867.USD","LU1720051108.HKD","LU1732799900.SGD","IE0004445239.USD","LU1037948541.HKD","VHT","BK4566","JDOC","BK4588","LU2023251221.USD","LU0661504455.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673812780","title":"Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673812780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673812780?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1720051108.HKD","LU1430594728.SGD","IE000BZT7R73.USD","LU0320765646.SGD","LU0553294199.USD","JDOC","BK4534","LU1037948541.HKD","LU1732799900.SGD","LU1236620834.HKD","ABBV","BK4588","LU0128525929.USD","IXJ","BK4566","IE00BDGV0183.EUR","VHT","XLV","FHLC","LU0203345920.USD","LU1162221912.USD","LU1267930573.SGD","LU1934455863.HKD","LU1236620750.USD","MEDX","LU0158827948.USD","SG9999015978.USD","IE00B3PB1722.GBP","LU1585245621.USD","PJP","FTXH","IE00BGHQF631.EUR","IE0004445239.USD","IE000SO60NU8.SGD","LU0234570918.USD","LU0661504455.SGD","BK4550","IE0002141913.USD","LU2023251221.USD","TRUH","LU0943347566.SGD","RXL","AGNG","LU1023059063.AUD","LU2237443978.SGD","PPH","GLAM","IYH","LU0170899867.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220081","title":"Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673220081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","ABBV","LU0823416689.USD","LU1003077747.HKD","LU1585245621.USD","LU1244550577.SGD","LU2357305700.SGD","LU1267930573.SGD","LU1720051017.SGD","FTXH","AGNG","PPH","LU0211327993.USD","IXJ","JDOC","IE00BGHQF631.EUR","GLAM","LU1496350502.SGD","LU0738911758.USD","LU0545039389.USD","LU0795875169.SGD","IE00BSNM7G36.USD","LU0689626769.HKD","TRUH","LU0203347892.USD","LU0124676726.USD","LU2237443978.SGD","LU0158827948.USD","VHT","LU0058720904.USD","BK4581","IYH","LU0912757837.SGD","LU2237443895.HKD","BK4534","LU0795875086.SGD","LU0708994859.HKD","LU2087621335.USD","FHLC","PJP","LU0661504455.SGD","LU2129689431.USD","RXL","LU0553294199.USD","XLV","BK4139","LU1061106388.HKD","LU1551013425.SGD","LU0114720955.EUR","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081273","title":"Abbvie Inc. Fy2026 Shr View $14.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081273?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRUH","LU0098860793.USD","AGNG","SG9999003800.SGD","RXL","LU1923622614.USD","LU1983299246.USD","LU1093756168.USD","VHT","FTXH","LU2237443549.SGD","IYH","LU0965509010.AUD","LU0859254822.USD","LU0738911758.USD","LU1732799900.SGD","LU2347655073.USD","IXJ","LU1057294990.SGD","IE0004445239.USD","LU0203345920.USD","LU0256863902.USD","LU1003077747.HKD","LU0058720904.USD","LU1720051108.HKD","LU2237443622.USD","MEDX","LU0122379950.USD","PJP","LU1061106388.HKD","IE00BJT1NW94.SGD","PPH","IE00B3PB1722.GBP","BK4581","LU2237443465.HKD","LU2125909247.SGD","LU1718418525.SGD","SG9999015952.SGD","LU0057025933.USD","LU2125909593.SGD","LU0943347566.SGD","FHLC","GLAM","LU0417517546.SGD","SG9999015978.USD","LU1989772923.USD","XLV","JDOC","ABBV","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081227","title":"Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081227?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MEDX","AGNG","LU0170899867.USD","RXL","LU1244550221.USD","LU2237443382.USD","PPH","JDOC","FHLC","LU0256863811.USD","LU1929549753.HKD","FTXH","LU0472753341.HKD","LU1934455194.USD","LU2089283258.USD","LU2112291526.USD","LU2125909593.SGD","PJP","IE00BLSP4452.SGD","LU1718418525.SGD","BK4581","IYH","IE00B3PB1722.GBP","LU0511384066.AUD","LU0395794307.EUR","IE00BN8TJ469.HKD","LU2237443622.USD","LU1037948897.HKD","LU2237443465.HKD","LU2347655073.USD","IE00B19Z3B42.SGD","GLAM","LU1074936037.SGD","XLV","LU1839511570.USD","VHT","LU0058720904.USD","BK4534","LU0949170772.SGD","LU1236620750.USD","LU1023059063.AUD","LU1496350502.SGD","TRUH","SG9999001440.SGD","LU0289961442.SGD","ABBV","LU0689472784.USD","IXJ","SG9999015945.SGD","LU0861579265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673819760","title":"Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673819760","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673819760?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:50","pubTimestamp":1791229824,"startTime":"0","endTime":"0","summary":"Genmab  and AbbVie  said that adding their drug epcoritamab to a standard chemotherapy mix helped people with an aggressive form of blood cancer stay cancer-free longer than chemotherapy alone.The combination cut the risk of the cancer getting worse or the patient dying by 51% compared with standard treatment alone, the companies said Monday in a statement. Results were from a large study in newly diagnosed patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma.The treatment paired epcoritamab with R-CHOP, a long-used chemotherapy regimen. The companies said the safety of the combination looked generally similar to what doctors already expect from each drug on its own.Because the treatment is still experimental, Genmab and AbbVie plan to meet with regulators around the world to discuss next steps.Genmab shares rose 11% in Monday trading, and AbbVie gained 1.3%.Price: 38.72, Change: +3.97, Percent Change: +11.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRUH","LU2237443549.SGD","VHT","LU2237443465.HKD","LU1983299246.USD","LU0395794307.EUR","SG9999015945.SGD","LU2237443382.USD","IYH","LU1839511570.USD","XLV","LU0158827948.USD","PPH","LU0128525929.USD","FTXH","IE00BVYPNW00.USD","LU2347655156.SGD","FHLC","JDOC","IE00BSNM7G36.USD","LU2089284900.SGD","LU2347655073.USD","LU0256863811.USD","LU0942090050.USD","SG9999003800.SGD","LU1923622614.USD","IE00B4R5TH58.HKD","LU0689626769.HKD","PJP","LU2125909593.SGD","LU2129689605.HKD","LU0965509101.SGD","LU1989772840.SGD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU1244550221.USD","LU1057294990.SGD","LU2089283258.USD","LU0859254822.USD","ABBV","AGNG","GLAM","LU0795875169.SGD","IE00BLSP4239.USD","LU1162221912.USD","BK4581","MEDX","GMAB","RXL","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673811030","title":"Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673811030","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673811030?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:47","pubTimestamp":1791229638,"startTime":"0","endTime":"0","summary":"An announcement from Genmab ( ($GMAB) ) is now available. Genmab and AbbVie reported on October 5, 2026, that their Phase 3 EPCORE DLBCL-2 trial sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXL","VHT","LU1551013342.USD","ABBV","LU1670628061.USD","LU0456855351.SGD","IYH","PJP","XLV","LU0289739699.SGD","BK4559","LU2357305700.SGD","IE00B4R5TH58.HKD","LU1496350502.SGD","GLAM","LU0823416689.USD","LU2089284900.SGD","LU2237443382.USD","LU2468319806.SGD","AGNG","BK4588","IE00BDGV0183.EUR","LU1929549753.HKD","JDOC","LU2237443978.SGD","TRUH","IE000SO60NU8.SGD","BK4581","FHLC","MEDX","LU0158827948.USD","LU0965509283.SGD","FTXH","LU0965509101.SGD","LU1037948897.HKD","LU1236620750.USD","LU1244550221.USD","LU0689626769.HKD","LU1037948541.HKD","BK4585","IXJ","BK4550","LU2237443465.HKD","PPH","LU1718418525.SGD","LU1074936037.SGD","IE000F7OJYX1.SGD","IE00B3PB1722.GBP","LU0122379950.USD","LU1720051017.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673363081","title":"AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673363081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673363081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:36","pubTimestamp":1791228977,"startTime":"0","endTime":"0","summary":"AbbVie blood cancer drug combo cuts risk of progression or death in late-stage studyOct 5 (Reuters)-Danish biotech firm GenmabGMAB.COand US drugmaker AbbVieABBV.Nsaid on Monday their combination treat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655073.USD","VHT","FTXH","IE00B4R5TH58.HKD","LU2237443465.HKD","RXL","IE00BN8TJ469.HKD","LU0942090050.USD","LU1923622614.USD","LU2237443549.SGD","LU0795875169.SGD","IE00BLSP4239.USD","IE00BFTCPJ56.SGD","LU2089284900.SGD","IE000MB6IJN5.SGD","LU0395794307.EUR","LU2237443382.USD","BK4581","LU2129689605.HKD","MEDX","LU0158827948.USD","LU1162221912.USD","XLV","LU0859254822.USD","LU2089283258.USD","IXJ","LU2125909593.SGD","AGNG","PPH","LU1989772840.SGD","LU1983299246.USD","LU1839511570.USD","TRUH","IE00BSNM7G36.USD","IE00BVYPNW00.USD","LU1244550221.USD","FHLC","PJP","LU0128525929.USD","LU0689626769.HKD","ABBV","GLAM","LU0256863811.USD","JDOC","SG9999015945.SGD","LU0965509101.SGD","LU2347655156.SGD","IYH","LU1057294990.SGD","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311081","title":"Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311081","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:55","pubTimestamp":1791226515,"startTime":"0","endTime":"0","summary":"Genmab A/S (GMAB) and AbbVie (ABBV) announced “positive” topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDX","TRUH","LU2433249047.HKD","LU1720051108.HKD","VHT","LU1023059063.AUD","LU0395794307.EUR","LU0289739699.SGD","LU1934455194.USD","LU0069063385.USD","IYH","XLV","LU0868494617.USD","LU0057025933.USD","LU0417517546.SGD","PPH","LU0128525929.USD","LU0211328371.USD","FTXH","LU0256863902.USD","LU1551013342.USD","FHLC","JDOC","LU0058720904.USD","LU0511384066.AUD","LU1585245621.USD","LU2089284900.SGD","LU2023251221.USD","LU2357627491.SGD","SG9999001440.SGD","SG9999015986.USD","PJP","LU0456855351.SGD","LU1934455277.USD","LU2087621335.USD","LU2125909593.SGD","LVIG","IE000MB6IJN5.SGD","LU0203345920.USD","LU1267930490.SGD","LU1074936037.SGD","LU0726765562.USD","ABBV","IE00BJT1NW94.SGD","GLAM","AGNG","RXL","LU1496350171.SGD","GMAB","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089429","title":"Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089429?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226259,"startTime":"0","endTime":"0","summary":"Genmab says Phase 3 EPCORE DLBCL-2 trial shows epcoritamab plus R-CHOP cuts progression or death risk 51% in newly diagnosed DLBCLGenmab, AbbVie reported positive topline Phase 3 results for epcoritam","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLWBPbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BJT1NW94.SGD","LU0310799852.SGD","RXL","VHT","ABBV","IYH","LU0882574055.USD","LU0912757837.SGD","IE00BGHQF748.EUR","PJP","XLV","IE00B19Z3B42.SGD","LU1023059063.AUD","GLAM","LU0198837287.USD","LU0114720955.EUR","LU2089283258.USD","LU2468319806.SGD","AGNG","BK4588","IE00B2B36J28.USD","LU1989771016.USD","JDOC","TRUH","IE000SO60NU8.SGD","BK4581","FHLC","MEDX","LU0158827948.USD","LU1923622614.USD","FTXH","LU1003077747.HKD","LU0859254822.USD","IE00B19Z3581.USD","IXJ","LU2095319765.USD","BK4550","PPH","IE00BN0W2V16.EUR","LU0234570918.USD","IE000WAW04H5.SGD","BCDF","IE00BQXX3F31.USD","LU0289961442.SGD","LU1720051017.SGD","LU0943347566.SGD","LU1585245621.USD","LU0320765646.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894940","title":"Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3581.USD","RXL","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU1267930573.SGD","TRUH","LU0310799852.SGD","LU1551013425.SGD","LU0882574055.USD","LU0289961442.SGD","LU0158827948.USD","GLAM","BK4550","BK4581","LU0859254822.USD","LU0198837287.USD","IXJ","LU0234570918.USD","LU0553294199.USD","LU0320765646.SGD","AGNG","IE00B19Z3B42.SGD","LU1003077747.HKD","FTXH","LU0965509010.AUD","LU2089283258.USD","LU0943347566.SGD","LU1585245621.USD","BK4588","FHLC","XLV","LU1923622614.USD","PJP","IE000WAW04H5.SGD","IYH","JDOC","VHT","LU1989771016.USD","PPH","IE0000B7K699.USD","LU0114720955.EUR","LU0912757837.SGD","ABBV","MEDX","LU1720051017.SGD","LU2468319806.SGD","LU0456855351.SGD","IE00BBT3K403.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894110","title":"Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894110?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","BK4566","GLAM","LU1989772923.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU1551013425.SGD","BK4534","RXL","IE00BJT1NW94.SGD","LU0949170772.SGD","LU0128525929.USD","LU0965509101.SGD","VHT","LU0868494617.USD","LU1244550577.SGD","FHLC","LU0795875169.SGD","BK4550","LU0234570918.USD","LU2023251221.USD","LU0417517546.SGD","PJP","LU0708994859.HKD","TRUH","FTXH","LU1548497426.USD","ABBV","LU1934455277.USD","XLV","LU0861579265.USD","SG9999015952.SGD","LU0738911758.USD","LU0689626769.HKD","PPH","MEDX","LU0256863811.USD","LU0256863902.USD","LU0795875086.SGD","JDOC","IYH","LU0456855351.SGD","IXJ","LU2237443382.USD","IE0004445239.USD","IE00BVYPNV92.GBP","AGNG","LU2357627491.SGD","LU2129689605.HKD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089491","title":"Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089491?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765646.SGD","LU2237443382.USD","VHT","AGNG","ABBV","LU2112291526.USD","FHLC","LU2129689605.HKD","LU1093756168.USD","GLAM","XLV","LU1236620750.USD","LU2089284900.SGD","IE00B19Z3B42.SGD","RXL","IE000BZT7R73.USD","LU1267930573.SGD","LU1989772840.SGD","LU1551013342.USD","LU1720051108.HKD","LU2089984988.USD","LU2129689514.USD","MEDX","IXJ","PJP","IE00B3PB1722.GBP","LU1934455863.HKD","IE00BVYPNW00.USD","LU2433249047.HKD","LU1934455277.USD","LU0511384066.AUD","LU0823416689.USD","TRUH","IYH","LU1267930490.SGD","LU2087621335.USD","BK4585","LU0868494617.USD","IE000SO60NU8.SGD","JDOC","LU0820561909.HKD","LU1585245621.USD","LU1923622614.USD","FTXH","PPH","LU1037948897.HKD","LU0868494708.USD","LU0689472784.USD","LU1023059063.AUD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":1,"totalSize":349,"code":"91000000","status":"200"}]}}